Literature DB >> 9854959

Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria.

J D Mitchell1, A C Gatrell, A Al-Hamad, R B Davies, G Batterby.   

Abstract

OBJECTIVES: To seek objective evidence for geographical clustering of places of residence of patients with motor neuron disease (MND).
METHODS: A complete residential history from birth to onset of disease was obtained from a cohort of 130 patients with MND from Lancashire and south Cumbria presenting to the Department of Neurology in Preston between 1 January 1989 and 31 December 1993. These data were compared with population based reference data from the 1991 UK Census.
RESULTS: Some areal units showed a greater, others a lesser, number of MND patient residences than expected. The results suggest that the background population incidence of MND is relatively low and that the overall incidence figures previously quoted have been skewed upwards by areas in which the incidence of MND is relatively increased. These findings were further tested by Poisson modelling. The Poisson model provided a poor fit for the data at postcode district and sector levels confirming that patients with MND were significantly more likely to have lived in some areas than others after allowing for variation in population of the different areal units and for variation in duration of residence.
CONCLUSIONS: These findings reinforce the results of previous work, much of which has been qualitative rather than quantitative. The results presented here suggest a low background incidence of MND in the context of generally quoted overall incidence figures. This low background incidence is, however, skewed upwards by some areal units with a relatively high incidence, thus achieving overall incidence rates comparable with generally quoted figures. We conclude that there is prima facie evidence of spatial patterns in the distribution of places of residence of patients with MND. Further examination of occupational and environmental factors in the lives of the patients with MND is required to obtain a better understanding of the importance of these findings.

Entities:  

Mesh:

Year:  1998        PMID: 9854959      PMCID: PMC2170391          DOI: 10.1136/jnnp.65.6.842

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin.

Authors:  J A Taylor; J P Davis
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

2.  Incidence of motor neurone disease in the northern region.

Authors:  N Qizilbash; D Bates
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

3.  Letter: Clustering of amyotrophic lateral sclerosis.

Authors:  F H Hochberg; J A Bryan; M A Whelan
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

5.  The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients.

Authors:  M Jokelainen
Journal:  J Neurol Sci       Date:  1976-09       Impact factor: 3.181

6.  Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community.

Authors:  D G Sienko; J P Davis; J A Taylor; B R Brooks
Journal:  Arch Neurol       Date:  1990-01

7.  Motor neurone disease in the Lothian Region of Scotland 1961-81.

Authors:  S M Holloway; J D Mitchell
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

8.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

9.  Birthplace as a risk factor in motor neurone disease and Parkinson's disease.

Authors:  E J Betemps; C R Buncher
Journal:  Int J Epidemiol       Date:  1993-10       Impact factor: 7.196

10.  Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study.

Authors:  J D Mitchell; H N Gibson; A Gatrell
Journal:  Arch Neurol       Date:  1990-08
View more
  6 in total

1.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

2.  Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy.

Authors:  Vittorio Govoni; Edward Cesnik; Ilaria Casetta; Valeria Tugnoli; Maria Rosaria Tola; Enrico Granieri
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

Review 3.  A systematic review of the incidence and prevalence of long-term neurological conditions in the UK.

Authors:  Thomas Hoppitt; Hardev Pall; Mel Calvert; Paramjit Gill; Guiqing Yao; Jill Ramsay; Gill James; Jacky Conduit; Cath Sackley
Journal:  Neuroepidemiology       Date:  2010-11-17       Impact factor: 3.282

4.  Incidence of amyotrophic lateral sclerosis in Europe.

Authors:  Giancarlo Logroscino; Bryan J Traynor; Orla Hardiman; Adriano Chiò; Douglas Mitchell; Robert J Swingler; Andrea Millul; Emma Benn; Ettore Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

5.  Spatial analyses of ALS incidence in Denmark over three decades.

Authors:  Verónica M Vieira; Johnni Hansen; Ole Gredal; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-01-31       Impact factor: 4.092

6.  Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.

Authors:  Judith M Burchardt; Xue W Mei; Tom Ranger; Christopher J McDermott; Aleksandar Radunovic; Carol Coupland; Julia Hippisley-Cox
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-02-01       Impact factor: 3.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.